Can this agreement be signed electronically?

Yes. Electronic signatures meet legal validity under the federal ESIGN Act (15 U.S.C. ch. 96) and state UETA rules when intent, consent, attribution, and record retention are demonstrable.

Is a Business Associate Agreement required?

If the recipient will access or process PHI, include a HIPAA Business Associate Agreement and ensure the platform supports a BAA for compliance with HIPAA rules.

What authentication is appropriate for signatures?

Use at least email-based authentication; consider SMS codes or identity verification for higher assurance. Document chosen method in the audit trail for evidentiary purposes.

How long must signed agreements be retained?

Retain signed agreements per applicable law: HIPAA-related records for 6 years (45 CFR §164.530(j)), financial records per IRC §6501(a) for 3 years, and longer if state law requires it.

Are notarization or witnesses required?

Most sample transfers do not require notarization, but state rules can differ. For enforceability in certain jurisdictions, include notarization or witnesses as specified in state law.

What if a signature name doesn't match records?

Mismatched signer names can raise admissibility concerns. Confirm authorized signatory names and titles before execution and include attestation language if necessary.

Electronic Signature
Templates
Healthcare
Healthcare Samples Agreement

Healthcare Samples Agreement

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

HEALTHCARE SAMPLES AGREEMENT

Parties and Effective Date

This Healthcare Samples Agreement (the "Agreement") is made between Sample Provider: and Sample Recipient: . Effective Date:

Recitals and Purpose

The parties desire to transfer patient biological specimens, associated clinical information, and related materials (collectively, "Samples") for the purpose of diagnostic testing, analysis, and permitted research as set forth in this Agreement. The parties agree to comply with applicable law, professional standards, and the terms below.

Definitions

"Confidential Information" means non-public information, including patient health information, sample test data, and proprietary methods disclosed in connection with Samples. "De-identified" means information rendered in a manner that no reasonable means exist to re-identify the Patient. "PHI" refers to protected health information as defined by applicable privacy law.

Patient Information (for Samples)

Patient Full Name

Date of Birth

Gender

Address

Phone

Emergency Contact

Insurance & Clinical Information

Insurance Provider

Policy / ID Number

Group Number

Medical History & Sample Details

Current Medications Allergies Prior Surgeries / Chronic Conditions Sample Description

Intended Use / Purpose

Collection, Chain of Custody, Packaging and Transport

Collector Name: Facility:

Chain of Custody Notes

Shipping Carrier: Tracking / Waybill:

All packaging, labeling and transport shall comply with applicable biohazard, DOT and other regulatory requirements. Recipient shall notify Provider within 24 hours of receipt of any compromised shipment.

Use, Ownership, and Return or Destruction of Samples

Provider retains ownership of Samples unless otherwise agreed in writing. Recipient is granted a limited, non-transferable license to use Samples solely for the Intended Use described above. Recipient shall not sell, sublicense, or use Samples for commercial product development without Provider's prior written consent.

Upon completion of the Intended Use or upon termination of this Agreement, Recipient shall, at Provider's direction, either return Samples to Provider or destroy Samples and certify destruction in writing within 30 days.

Confidentiality and Privacy; HIPAA Authorization

Recipient shall maintain the confidentiality of PHI and Confidential Information and shall implement administrative, physical, and technical safeguards to protect such information. Recipient shall use and disclose PHI only as permitted by this Agreement and applicable law.

Patient Authorization: By initiating transfer of the Sample, Provider represents that it has obtained all necessary consents and authorizations from the patient or the patient's lawful representative for the transfer and permitted uses described herein, including any required HIPAA authorization where applicable.

HIPAA Authorization Acknowledgment

I certify that appropriate HIPAA authorization or other lawful basis for the disclosure and use of PHI has been obtained and recorded.

Authorization Expiration Date

Representations, Warranties and Indemnification

Each party represents and warrants that it has the authority to enter this Agreement and that the information provided is true and complete. Recipient shall indemnify, defend and hold harmless Provider from any third-party claims arising from Recipient's negligent handling or unauthorized use of Samples, except to the extent caused by Provider's breach or willful misconduct.

Insurance and Liability

Each party shall maintain appropriate insurance coverage for its activities under this Agreement. Neither party shall be liable for incidental or consequential damages except to the extent such damages result from gross negligence or willful misconduct.

Compensation and Fees

Sample transfer fees, testing fees, and payment terms shall be as follows. Fee Arrangement:

If no fee applies, indicate:

Records, Audit Rights, and Retention

Each party shall retain records relating to Samples, consents, and disclosures for the period required by law. Provider or its designee may audit Recipient's compliance with this Agreement upon reasonable notice and during normal business hours.

Term, Termination and Survival

This Agreement commences on the Effective Date and continues until terminated by either party upon thirty (30) days' written notice. Obligations regarding confidentiality, return or destruction of Samples, indemnification and record retention shall survive termination.

Notices

Provider Notice Address Recipient Notice Address

Governing Law and Dispute Resolution

This Agreement shall be governed by the laws of the jurisdiction specified by the parties. Disputes shall be resolved by binding arbitration or in a court of competent jurisdiction as elected by the non-breaching party, provided such selection is consistent with governing law.

Miscellaneous Provisions

This Agreement constitutes the entire agreement between the parties regarding Samples and supersedes prior agreements. Any amendment must be in writing and signed by authorized representatives of both parties.

Acknowledgment and Certification

Each party certifies that the individual signing below is authorized to bind the respective party to the terms of this Agreement. Provider certifies that patient consents and authorizations required for the transfer and disclosed uses of Samples have been obtained and are documented.

Provider Name:

By:

Date:

Recipient Name:

By:

Date:

What a Healthcare Samples Agreement Covers

A Healthcare Samples Agreement is a written contract that governs the collection, transfer, testing, storage, use, and disposition of biological or clinical samples between a provider, laboratory, research organization, or third party. The agreement identifies parties, sample types, permitted uses, labeling and chain-of-custody procedures, confidentiality and data handling practices, intellectual property rights if applicable, compensation or cost recovery, indemnity and liability allocation, and the procedures for returning or destroying leftover material. For healthcare contexts it should explicitly address protected health information handling and any required authorizations under HIPAA.

Why this agreement matters for providers and labs

A clear Healthcare Samples Agreement reduces regulatory risk, documents patient or donor consent, protects PHI, preserves chain of custody, and sets expectations for sample handling, ownership, and downstream use. It creates an auditable record that supports compliance and defensible business practices.

Who typically completes a Healthcare Samples Agreement

Several organizations and roles commonly prepare or sign these agreements depending on purpose and custody of material.

Clinical laboratories and pathology groups that receive and test patient specimens for diagnostic purposes.
Healthcare providers and hospitals that transfer patient-derived samples to external labs or research partners.
Research institutions, CROs, and biobanks managing consented sample use for studies or commercial development.

Parties should route the agreement for review by compliance, legal, and privacy officers where PHI, informed consent, or material transfer terms are involved.

Core elements to include in a professional agreement

A complete document lists technical, legal, and administrative terms so both parties have operational clarity and regulatory coverage.

Parties

Full legal names and contact information for provider, recipient laboratory, billing party, and any custodial agent; specify roles and authorized signatories.

Sample Details

Precise description of sample types, identifiers, acceptable containers, required labeling, and any biosafety or shipping conditions.

Permitted Uses

Define allowed activities (diagnostic testing, research, method development, storage) and any prohibited secondary uses or commercialization.

Consent & PHI

Citation of patient consent or authorization language, handling of protected health information, and any required HIPAA business associate agreement terms.

Chain of Custody

Procedures for transfer, documentation, transport conditions, sample tracking, and required signatures or electronic audit records.

Disposition

Retention period for residual samples, destruction or return procedures, and conditions that trigger sample transfer or disposal.

Step-by-step: completing and executing the agreement

Follow these steps to prepare, review, and finalize a Healthcare Samples Agreement with proper compliance and documentation.

01

Draft core terms: Populate parties, sample details, permitted uses, and retention.
02

Conduct compliance review: Have privacy and legal review HIPAA language and consent alignment.
03

Obtain patient consent: Document explicit authorization when PHI or identifiable samples are involved.
04

Sign and store: Execute by authorized signers and retain a secure, auditable copy.

Configuring an online workflow for this agreement

Set up a repeatable electronic workflow to reduce errors, capture audit trails, and meet retention obligations.

Field	Configuration
Signer Order	Sequential or parallel signing depending on required approvals.
Authentication	Email link with optional SMS or identity verification for higher assurance.
Conditional Fields	Show consent language only when PHI or identified samples are selected.
Audit Trail	Enable IP, timestamp, and action logging for every signer event.

Where to file or submit the executed agreement

After execution, distribute copies and file centrally so clinical, legal, and compliance teams can access the record.

Clinical Records: Attach signed agreement to the patient chart or specimen intake file.
Laboratory Files: Store the executed agreement alongside chain-of-custody and test logs.
Compliance Repository: Retain an immutable copy for audits and regulatory review.
Research Archive: Link agreements to study documentation and informed consent records.

Technical considerations for eSignature and eSubmission

Confirm platform capabilities align with legal, privacy, and operational needs before executing electronically.

Audit Trail: Capture IP, timestamps, and signer actions.
PHI Controls: BAA availability and encryption at rest required.
Integration: Connect to EHR or LIMS for automatic indexing.

Ensure the provider supports required authentication, secure storage (AES-256), and export in standard formats to satisfy legal and operational reviews.

Typical timelines and processing expectations

Timelines depend on purpose (diagnostic versus research) and the parties' operational SLAs; document specific turnaround and retention deadlines in the agreement.

Effective Date:

Agreement date sets when obligations begin; use MM/DD/YYYY to avoid ambiguity.

Sample Transfer Window:

Specify shipping deadlines (e.g., within 48–72 hours of collection) to preserve viability.

Testing Turnaround:

Document expected lab result timeframe, for example 24–72 hours for routine assays.

Residual Sample Retention:

State retention period for leftover material, typically defined in months or years.

Record Retention:

Retain executed agreements and audit logs per regulatory obligations noted in agreement.

Common mistakes to avoid when preparing the agreement

Vague permitted-use language that allows unanticipated secondary research or commercialization.
Failing to document explicit patient authorization when samples are identifiable or linked to PHI.
Omitting chain-of-custody procedures or transport conditions that preserve sample integrity.
Using unsigned or improperly authorized signatures, which can invalidate transfer or testing consent.

Key penalties and legal risks from errors

HIPAA Penalties: Civil and criminal fines; breach reporting obligations.

Invalid Consent: Tests may be inadmissible or subject to litigation.

Chain-of-Custody Failure: Results may be challenged and liability increased.

Regulatory Action: Enforcement by state agencies or CMS for lab violations.

Contract Liability: Indemnity and damages if handling obligations breach.

Reputational Harm: Loss of trust with patients and partners.

eSignature platform comparison for executing Healthcare Samples Agreements

Compare common eSignature vendor pricing and compliance features relevant to healthcare agreements; signNow is listed first per vendor table convention.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial, no card	Varies by plan	Varies by plan	Varies by plan	Varies by plan
Bulk Send	Yes	Yes	Yes	Yes	Varies
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No
Envelope Cap	No envelope cap	100 envelopes/user/year	Varies by plan	Varies by plan	Varies by plan

Frequently asked questions about Healthcare Samples Agreements

Answers address execution, electronic signatures, privacy, and recordkeeping concerns commonly raised by providers, labs, and researchers.

Need help? Contact support

Can this agreement be signed electronically?
Yes. Electronic signatures meet legal validity under the federal ESIGN Act (15 U.S.C. ch. 96) and state UETA rules when intent, consent, attribution, and record retention are demonstrable.
Is a Business Associate Agreement required?
If the recipient will access or process PHI, include a HIPAA Business Associate Agreement and ensure the platform supports a BAA for compliance with HIPAA rules.
What authentication is appropriate for signatures?
Use at least email-based authentication; consider SMS codes or identity verification for higher assurance. Document chosen method in the audit trail for evidentiary purposes.
How long must signed agreements be retained?
Retain signed agreements per applicable law: HIPAA-related records for 6 years (45 CFR §164.530(j)), financial records per IRC §6501(a) for 3 years, and longer if state law requires it.
Are notarization or witnesses required?
Most sample transfers do not require notarization, but state rules can differ. For enforceability in certain jurisdictions, include notarization or witnesses as specified in state law.
What if a signature name doesn't match records?
Mismatched signer names can raise admissibility concerns. Confirm authorized signatory names and titles before execution and include attestation language if necessary.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now